NO177794C - Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten - Google Patents
Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåtenInfo
- Publication number
- NO177794C NO177794C NO882918A NO882918A NO177794C NO 177794 C NO177794 C NO 177794C NO 882918 A NO882918 A NO 882918A NO 882918 A NO882918 A NO 882918A NO 177794 C NO177794 C NO 177794C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- nucleic acid
- well
- host cell
- fusion protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868626148A GB8626148D0 (en) | 1986-11-01 | 1986-11-01 | Antigen presentation & purification system |
GB878708532A GB8708532D0 (en) | 1987-04-09 | 1987-04-09 | Particulate hybrid hiv antigens |
US3688887A | 1987-04-10 | 1987-04-10 | |
PCT/GB1987/000763 WO1988003562A1 (en) | 1986-11-01 | 1987-10-28 | Particulate hybrid hiv antigens |
Publications (4)
Publication Number | Publication Date |
---|---|
NO882918D0 NO882918D0 (no) | 1988-06-30 |
NO882918L NO882918L (no) | 1988-08-29 |
NO177794B NO177794B (no) | 1995-08-14 |
NO177794C true NO177794C (no) | 1995-11-22 |
Family
ID=27263195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO882918A NO177794C (no) | 1986-11-01 | 1988-06-30 | Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0329671B1 (no) |
JP (1) | JPH02501107A (no) |
AU (1) | AU606627B2 (no) |
DE (1) | DE3788806T2 (no) |
ES (1) | ES2010230A6 (no) |
HU (1) | HUT50875A (no) |
NO (1) | NO177794C (no) |
WO (1) | WO1988003562A1 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3006789A (en) * | 1988-02-24 | 1989-08-24 | Smithkline Beckman Corporation | Expression of hiv binding proteins |
US5631154A (en) * | 1988-06-10 | 1997-05-20 | Therion Biologics, Incorporated | Self assembled, defective, non-self-propagating lentivirus particles |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
US5747324A (en) * | 1988-06-10 | 1998-05-05 | Therion Biologics Corporation | Self-assembled, defective, non-self-propagating lentivirus particles |
EP0361749B1 (en) * | 1988-09-27 | 1995-02-08 | Dana Farber Cancer Institute | A vector comprising a replication competent HIV-I provirus and a heterologous gene |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
AU4665389A (en) * | 1988-11-23 | 1990-06-12 | Regents Of The University Of California, The | Position-specific insertion vectors and method of using same |
JP3034025B2 (ja) * | 1989-06-01 | 2000-04-17 | アプライド・バイオテクノロジー・インコーポレーテツド | 自己アセンブルド欠損非自己増殖性ウイルス粒子 |
GB8923123D0 (en) * | 1989-10-13 | 1989-11-29 | Connaught Lab | A vaccine for human immunodeficiency virus |
US5989886A (en) * | 1991-01-02 | 1999-11-23 | The Johns Hopkins University | Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme |
GB9107631D0 (en) * | 1991-04-10 | 1991-05-29 | British Bio Technology | Proteinaceous particles |
AU2462392A (en) * | 1992-04-14 | 1993-11-18 | British Biotech Pharmaceuticals Limited | Induction of CTL responses |
WO1994016084A1 (en) * | 1993-01-16 | 1994-07-21 | British Bio-Technology Limited | Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens |
FR2703996B1 (fr) * | 1993-04-16 | 1995-07-21 | Transgene Sa | Ensemble de transposition destine au transfert d'un gene d'interet dans le genome d'une cellule eucaryote. |
DE4335025A1 (de) * | 1993-10-14 | 1995-04-20 | Boehringer Ingelheim Int | Endosomolytisch wirksame Partikel |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
EP0907740A1 (en) * | 1997-01-02 | 1999-04-14 | Universidade Federal De Minas Gerais | THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR76274B (no) * | 1981-08-04 | 1984-08-04 | Univ California | |
JP2708046B2 (ja) * | 1986-11-01 | 1998-02-04 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 融合タンパク質および粒子 |
-
1987
- 1987-10-28 EP EP87907014A patent/EP0329671B1/en not_active Expired - Lifetime
- 1987-10-28 WO PCT/GB1987/000763 patent/WO1988003562A1/en active IP Right Grant
- 1987-10-28 HU HU875702A patent/HUT50875A/hu unknown
- 1987-10-28 DE DE3788806T patent/DE3788806T2/de not_active Expired - Fee Related
- 1987-10-28 JP JP62506486A patent/JPH02501107A/ja active Pending
- 1987-10-28 AU AU81534/87A patent/AU606627B2/en not_active Ceased
- 1987-10-30 ES ES8703104A patent/ES2010230A6/es not_active Expired
-
1988
- 1988-06-30 NO NO882918A patent/NO177794C/no unknown
Also Published As
Publication number | Publication date |
---|---|
ES2010230A6 (es) | 1989-11-01 |
DE3788806T2 (de) | 1994-07-07 |
NO882918D0 (no) | 1988-06-30 |
NO882918L (no) | 1988-08-29 |
NO177794B (no) | 1995-08-14 |
AU8153487A (en) | 1988-06-01 |
WO1988003562A1 (en) | 1988-05-19 |
EP0329671A1 (en) | 1989-08-30 |
AU606627B2 (en) | 1991-02-14 |
DE3788806D1 (de) | 1994-02-24 |
HUT50875A (en) | 1990-03-28 |
EP0329671B1 (en) | 1994-01-12 |
JPH02501107A (ja) | 1990-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO177793C (no) | Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten | |
NO177794C (no) | Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten | |
NO175715C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive aminosyrederivater, samt mellomprodukter ved fremstilling av disse | |
DK110885A (da) | Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf | |
IT7921838A0 (it) | Processo di rivelazione e di caratterizzazione di un acido nucleico o di una sua sequenza e reattivo enzimatico per la realizzazione di questo processo. | |
NO871785L (no) | Fremgangsmaate for fremstilling av et proteinprodukt samt vektorsystem for fremgangsmaatens utfoerelse. | |
DK374087D0 (da) | Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne | |
NO964445L (no) | DNA-sekvens, vektor, vertscelle og fremgangsmåte for transfeksjon av hematopoeseceller med eksogen DNA | |
NZ221790A (en) | Method for the continuous production of a heterologous protein in a eukaryotic host cell | |
ATE158816T1 (de) | Expression von pace in wirtszellen und verfahren zu dessen verwendung | |
DK158659C (da) | 2,4,6-triiod-isophthalsyrederivater, deres fremstilling og roentgenkontrastmidler indeholdende disse. | |
AU587989B2 (en) | DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins | |
ZA864525B (en) | Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained | |
NO179109C (no) | Ekspresjonsvektor, rekombinante vertsceller samt fremgangsmåte for fremstilling av terapeutisk aktivt, rekombinant CSF | |
DK388789D0 (da) | Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna | |
IT8520036A0 (it) | Processo per la preparazione biotecnologica di acidi alfa-arilalcanoici otticamente attivi. | |
DK534286A (da) | Nicotinsyrederivater, deres fremstilling og anvendelse som herbicider samt mellemprodukter ved fremstillingen og disses fremstilling | |
DK124787A (da) | Peptider indeholdende op til 8-aminosyregrupperinger og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen | |
DK354188D0 (da) | Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen | |
WO1994025590A3 (en) | Trichohyalin and transglutaminase-3 and methods of using same | |
DK94385D0 (da) | Proteiner, farmaceutiske praeparater, gener, vektorer, vaertsorganismer samt fremgangsmaader til deres fremstilling | |
NO874573D0 (no) | Nucleinsyreprober for paavisning av latent humant cytomegalovirus i lodprodukter. | |
AU5945386A (en) | Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin | |
NO178036C (no) | Fremgangsmåte for fremstilling av fusjonsproteiner, genstruktur, vektorer streptomycetceller og fusjonsproteinene | |
AU6521186A (en) | Lytic viruses as expression vectors, host cell containing same and process for protein production |